课题基金 / 基金详情

Prescription Drug Monitoring Program Integration in the Electronic Health Record

Prescription Drug Monitoring Program Integration in the Electronic Health Record
电子健康记录中的处方药监测计划集成
批准号:
10374016
负责人:
Daniel M Hartung
金额:
$15.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-04-01 至 2024-03-31

项目摘要

项目成果

Daniel M Hartung的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Prescription Drug Monitoring Programs (PDMPs) are state administered electronic registries of controlled-substance prescription dispensing data and are used by clinicians to inform prescribing decisions for medications of abuse. Now operating in every state and the District of Columbia, PDMPs are a central strategy in the nation’s response to the opioid overdose epidemic. A growing literature suggests that state PDMPs reduce high-risk opioid prescribing and opioid-related overdoses, particularly in states that mandate use in certain clinical situation. However, PDMP use varies among clinicians because access often entails interrupting the clinical workflow or patient care encounter. To promote increased PDMP use, multiple states are investing in technology that facilitates PDMP integration in other health information technology (HIT) platforms such as the electronic health record (EHR). In an effort to accelerate integration, the Oregon Health Authority is subsidizing PDMP EHR integration for healthcare systems across Oregon. Oregon Health & Science University (OHSU), one the largest healthcare systems in the state, will be one of the first healthcare systems to undergo PDMP integration within its EHR application (Epic™). OHSU is currently integrating PDMP access across twelve ambulatory primary care medicine clinics over a six-month period (four clinics starting every two months). The objective of this proposal is to evaluate the effect of PDMP integration on provider use and prescribing behavior. We accomplish this objective with two Specific Aims: (1) Determine the effect of PDMP EHR integration on provider PDMP use and, (2) Evaluate the effects of PDMP EHR integration on controlled substance prescribing. We will use an observational stepped-wedge design with data derived from OHSU EHR and the state’s PDMP program. We exploit the staggered implementation across OHSU clinics to estimate the effects of PDMP EHR integration on provider use of the PDMP (Aim 1) and prescribing behavior (Aim 2). Data generated from this project will inform PDMP integration efforts across the country and support a larger research proposal to study the effects that initiative on opioid prescribing and opioid-related overdose outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prescription Drug Monitoring Program Integration in the Electronic Health Record
  • 批准号:
    10196591
  • 项目类别:
  • 资助金额:
    $14.08万
  • 财政年份:
    2021
  • 负责人:
    Daniel M Hartung
  • 依托单位:
EpiCenter - EPIdemiology of opioid prescribing in community health CENTERs
  • 批准号:
    10625654
  • 项目类别:
  • 资助金额:
    $48.32万
  • 财政年份:
    2018
  • 负责人:
    Daniel M Hartung
  • 依托单位:
Prescription Opioid Performance Improvement Metrics and Heroin Abuse
  • 批准号:
    9338109
  • 项目类别:
  • 资助金额:
    $39.87万
  • 财政年份:
    2016
  • 负责人:
    Daniel M Hartung
  • 依托单位:
Prescription Opioid Performance Improvement Metrics and Heroin Abuse
  • 批准号:
    9225660
  • 项目类别:
  • 资助金额:
    $39.87万
  • 财政年份:
    2016
  • 负责人:
    Daniel M Hartung
  • 依托单位:
国内基金
海外基金
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    杨胜彩
  • 依托单位:
Drug-ADR-Pathway复合网络构建及ADR分子机制研究
  • 批准号:
    61372188
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    陈秀杰
  • 依托单位:
Drug-pHLA对接指纹图谱库的构建及HLA介导SADR的预测方法研究
  • 批准号:
    61073135
  • 项目类别:
    面上项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2010
  • 负责人:
    梅虎
  • 依托单位:
新型药物传输系统drug-LDHs 复合纳米粒子的可控制备及其微结构对缓控释性能的调控
  • 批准号:
    20776012
  • 项目类别:
    面上项目
  • 资助金额:
    31.0万元
  • 批准年份:
    2007
  • 负责人:
    张慧
  • 依托单位: